Studies have also demonstrated that CTLA-4 is constitutively expressed on tumor cell lines at various degrees of intensity and can trigger apoptosis of CTLA-4-expressing tumor cells after interaction with soluble CD80 or CD86 recombinant ligands [12]. The gene discussed is CTLA4; the disease is neoplasm.